This piece of content is part of multiple stories. We recommend you read this content in the context of one of the following stories:
Barack Obama visit may pressurise govt to dilute patent laws, fears medical body
Author: PB Jayakumar, Business Today, Published on: 21 January 2015
US President Barack Obama's visit to India is likely to accelerate ongoing pressure from the US on the Indian government to dilute its patent laws to help multinational drug makers, fears international medical humanitarian organisation Medecins Sans Frontieres/Doctors Without Borders (MSF)...The US multinational lobby is pressurising the Indian Government to dilute rules related to Section 3 (d) of Indian Patent Act on incremental innovations and Section 84 related to compulsory licensing (allowing generic companies to make drugs despite the patent) during emergencies.